HK1244215A1 - 包含富馬酸二甲酯的藥物基質製劑 - Google Patents

包含富馬酸二甲酯的藥物基質製劑

Info

Publication number
HK1244215A1
HK1244215A1 HK18103740.7A HK18103740A HK1244215A1 HK 1244215 A1 HK1244215 A1 HK 1244215A1 HK 18103740 A HK18103740 A HK 18103740A HK 1244215 A1 HK1244215 A1 HK 1244215A1
Authority
HK
Hong Kong
Prior art keywords
dimethyl fumarate
matrix formulations
pharmaceutical matrix
pharmaceutical
formulations
Prior art date
Application number
HK18103740.7A
Other languages
English (en)
Inventor
Shyam B Karki
Peter Zawaneh
Cheuk-Yui Leung
Yiqing Lin
Original Assignee
比奧根Ma公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 比奧根Ma公司 filed Critical 比奧根Ma公司
Publication of HK1244215A1 publication Critical patent/HK1244215A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18103740.7A 2014-11-19 2018-03-18 包含富馬酸二甲酯的藥物基質製劑 HK1244215A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462081907P 2014-11-19 2014-11-19
PCT/US2015/061448 WO2016081671A1 (en) 2014-11-19 2015-11-19 Pharmaceutical matrix formulations comprising dimethyl fumarate

Publications (1)

Publication Number Publication Date
HK1244215A1 true HK1244215A1 (zh) 2018-08-03

Family

ID=54838418

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18103740.7A HK1244215A1 (zh) 2014-11-19 2018-03-18 包含富馬酸二甲酯的藥物基質製劑

Country Status (13)

Country Link
US (2) US20190083404A1 (zh)
EP (1) EP3220897A1 (zh)
JP (2) JP6901393B2 (zh)
KR (1) KR20170086053A (zh)
CN (2) CN113262205A (zh)
AU (2) AU2015349891B2 (zh)
CA (1) CA2967645A1 (zh)
EA (1) EA201791089A1 (zh)
HK (1) HK1244215A1 (zh)
IL (1) IL252105A0 (zh)
MA (1) MA40990A (zh)
MX (1) MX2017006561A (zh)
WO (1) WO2016081671A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016194004A1 (en) 2015-06-01 2016-12-08 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
WO2023036702A1 (en) 2021-09-09 2023-03-16 It Pharmagus Limited Method for the manufacturing of a solid body as an oral dosage form of a pharmaceutical or a food supplement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1202815C (zh) * 1999-08-31 2005-05-25 格吕伦塔尔有限公司 含有曲马朵糖精盐的持续释放给药剂型
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
PT2379063E (pt) * 2009-01-09 2013-05-03 Forward Pharma As Formulação farmacêutica compreendendo um ou mais ésteres de ácido fumárico numa matriz de erosão
EP3466420A1 (en) * 2009-04-29 2019-04-10 Biogen MA Inc. Dimethyl fumarate for the treatment of friedreich ataxia
AU2012222074A1 (en) * 2011-02-25 2013-09-12 National Institutes Of Health Chalcone derivatives as Nrf2 activators
US20130158077A1 (en) * 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions
CN114146080A (zh) * 2012-02-07 2022-03-08 比奥根玛公司 含有富马酸二甲酯的药物组合物
AU2013305684B2 (en) * 2012-08-22 2016-11-24 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
JP6506174B2 (ja) * 2012-12-21 2019-04-24 バイオジェン エムエー インコーポレイテッド 重水素置換されたフマル酸誘導体
CN105369562B (zh) * 2014-08-28 2019-12-20 青岛海尔洗衣机有限公司 一种带有防衣物褪色提醒功能的洗衣机

Also Published As

Publication number Publication date
CN113262205A (zh) 2021-08-17
JP2021152046A (ja) 2021-09-30
JP2017534667A (ja) 2017-11-24
AU2021204247A1 (en) 2021-07-22
CN107205942A (zh) 2017-09-26
AU2015349891B2 (en) 2021-04-01
MX2017006561A (es) 2018-02-21
IL252105A0 (en) 2017-07-31
US20190175510A1 (en) 2019-06-13
WO2016081671A8 (en) 2016-07-21
US20190083404A1 (en) 2019-03-21
EP3220897A1 (en) 2017-09-27
CA2967645A1 (en) 2016-05-26
WO2016081671A1 (en) 2016-05-26
JP6901393B2 (ja) 2021-07-14
EA201791089A1 (ru) 2017-11-30
AU2015349891A1 (en) 2017-05-25
KR20170086053A (ko) 2017-07-25
MA40990A (fr) 2017-09-26

Similar Documents

Publication Publication Date Title
IL246978A0 (en) New paracetamol formulations
PT4070788T (pt) Formulações farmacêuticas
HK1254343A1 (zh) 藥物製劑
ZA201903101B (en) Pharmaceutical formulations
ZA201704263B (en) Controlled-release formulations
HK1244214A1 (zh) 包含富馬酸二甲酯的藥物珠粒製劑
IL262745A (en) Improved preparations containing drugs
GB201419261D0 (en) Formulations
GB201419091D0 (en) Formulations
HK1245653A1 (zh) 藥物製劑
ZA201707094B (en) Pharmaceutical formulations
IL253177A0 (en) Pharmacy preparation
HK1244215A1 (zh) 包含富馬酸二甲酯的藥物基質製劑
GB201506755D0 (en) Novel pharmaceutical formulation
GB201417589D0 (en) Pharmaceutical Formulations
GB201511246D0 (en) Pharmaceutical formulation
IL261073A (en) Pharmaceutical granular preparations containing dimethyl fumarate
GB201610440D0 (en) Pharmaceutical formulations
GB201407741D0 (en) Novel drug formulation
GB201400951D0 (en) Novel drug formulation